News

FDA rushed out agency-wide AI tool—it’s not going well
FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't ...
FDA plans to limit COVID vaccine to only high-risk people: What Oklahomans should know
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.
UPI29d
FDA says it will be 'aggressive' in adopting artificial intelligence in its labs
May 8 (UPI) --The Food and Drug Administration on Thursday announced what it called an aggressive agency-wide artificial intelligence adoption timeline, as well as a new AI tool to help scientists ...
JD Supra6mon
FDA now recommends only one study to show bioequivalence for certain oral drug products - FDA also revises several hundred product specific guidances to align with ICH M13A BE ...
The U.S. Food and Drug Administration (FDA) issued final guidance on “M13A Bioequivalence for Immediate-Release Solid Oral Dosage Forms,” which provides advice on conducting bioequivalence (BE ...
Hosted on MSN1mon
GraphBAN: Making drug discovery faster and more affordable through artificial intelligence
GraphBAN is an inductive graph-based approach. The model is all about discovering new drug candidates in the pre-clinical stage. This means speeding up the drug discovery process and making it ...
News Medical11mon
GCARDTI: Advancing drug-target interaction prediction with hybrid graph learning
The GCARDTI model uses highly robust drug SELFIES combined with target sequences to build heterogeneous networks, and input them into a hybrid mechanism of graph learning module to capture high ...